PREMIER Study for Uterovaginal Prolapse
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse [PREMIER Trial]
- Sex: Female
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Others
- Trial Phase: NA
- Conditions Being Studied: Other Female Genital, Pelvic Organ Prolapse
Study Purpose
The purpose of this research study is to compare the two most common corrective surgeries in the U.S. for uterovaginal prolapse (UVP). The goal of the study is to determine which surgery works best from a patient’s perspective and has the lowest number of short-term and long-term medical problems.
Who Can Participate
Women between 18 and 80 years of age and are diagnosed with symptomatic uterovaginal prolapse women may be eligible for this study.
Locations
UH Bedford Outpatient Campus
44 Blaine Ave
Bedford OH, 44146
UH Landerbrook Health Center
5850 Landerbrook Dr
Mayfield Heights OH, 44124
UH Richmond Heights Outpatient Campus
27100 Chardon Rd
Richmond Heights OH, 44143
- UH IRB: STUDY20210871
- StudyID: 2021-0665
- ClinicalTrials.gov: NCT05063331
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422